Biology Reference
In-Depth Information
Br
omme D, Li Z, Barnes M, Mehler E (1999) Human cathepsin V functional expression, tissue
distribution, electrostatic surface potential, enzymatic characterization, and chromosomal
localization. Biochemistry 38:2377-2385
Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF (1992) Degradation of extracellular-
matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 282
(Pt 1):273-278
Buhling F, Rocken C, Brasch F, Hartig R, Yasuda Y, Saftig P, Bromme D, Welte T (2004a) Pivotal
role of cathepsin K in lung fibrosis. Am J Pathol 164:2203-2216
Buhling F, Waldburg N, Reisenauer A, Heimburg A, Golpon H, Welte T (2004b) Lysosomal
cysteine proteases in the lung: role in protein processing and immunoregulation. Eur Respir J
23:620-628
Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front
Biosci 11:529-543
Butler GS, Overall CM (2009) Updated biological roles for matrix metalloproteinases and new
“intracellular” substrates revealed by degradomics. Biochemistry 48:10830-10845
Buttle DJ, Saklatvala J, Tamai M, Barrett AJ (1992) Inhibition of interleukin 1-stimulated cartilage
proteoglycan degradation by a lipophilic inactivator of cysteine endopeptidases. Biochem J
281:175-177
Buttle DJ, Handley CJ, Ilic MZ, Saklatvala J, Murata M, Barrett AJ (1993) Inhibition of cartilage
proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix
metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteo-
glycan degradation. Arthritis Rheum 36:1709-1717
Cheng XW, Kuzuya M, Nakamura K, Di Q, Liu Z, Sasaki T, Kanda S, Jin H, Shi GP, Murohara T,
Yokota M, Iguchi A (2006) Localization of cysteine protease, cathepsin S, to the surface of vas-
cular smooth muscle cells by association with integrin alphanubeta3. Am J Pathol 168:685-694
Choe Y, Leonetti F, Greenbaum DC, Lecaille F, Bogyo M, Bromme D, Ellman JA, Craik CS
(2006) Substrate profiling of cysteine proteases using a combinatorial peptide library identifies
functionally unique specificities. J Biol Chem 281:12824-12832
Chung L, Shimokawa KI, Nagase H (2000) Structural requirements for collagenolytic activity of
matrix metalloproteinase 1 (MMP-1). Kluwer Academic Publishers, Dordrecht, The Netherlands
Chung L, Dinakarpandian D, Yoshida N, Lauer-Fields JL, Fields GB, Visse R, Nagase H (2004)
Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis. EMBO J
23:3020-3030
Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky
ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW,
Weichselbaum RR, Sukhatme VP, Kalluri R (2000) Anti-angiogenic cues from vascular
basement membrane collagen. Cancer Res 60:2520-2526
Coulibaly S, Schwihla H, Abrahamson M, Albini A, Cerni C, Clark JL, Ng KM, Katunuma N,
Schlappack O, Glossl J, Mach L (1999) Modulation of invasive properties of murine squamous
carcinoma cells by heterologous expression of cathepsin B and cystatin C. Int J Cancer
83:526-531
de Nooijer R, Bot I, von der Thusen JH, Leeuwenburgh MA, Overkleeft HS, Kraaijeveld AO,
Dorland R, van Santbrink PJ, van Heiningen SH, Westra MM, Kovanen PT, Jukema JW, van
der Wall EE, van Berkel TJ, Shi GP, Biessen EA (2009) Leukocyte cathepsin S is a potent
regulator of both cell and matrix turnover in advanced atherosclerosis. Arterioscler Thromb
Vasc Biol 29:188-194
Deaton DN, Tavares FX (2005) Design of cathepsin K inhibitors for osteoporosis. Curr Top Med
Chem 5:1639-1675
Dejica VM, Mort JS, Laverty S, Percival MD, Antoniou J, Zukor DJ, Poole AR (2008) Cleavage of
type II collagen by cathepsin K in human osteoarthritic cartilage. Am J Pathol 173:161-169
Desmarais S, Black WC, Oballa R, Lamontagne S, Riendeau D, Tawa P, Duong le T, Pickarski M,
Percival MD (2008) Effect of cathepsin k inhibitor basicity on in vivo off-target activities. Mol
Pharmacol 73:147-156
€
